Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Minimally invasive endoscopes for neuronal activity monImaging-assisted single-cell specific activity monitoring and optogenetic stimulation of deep brain structures in motile and awaken animal models

WOKEGATE

Severe neuronal disorders such as dementia affect more than 1 billion people globally and account for economic burden far exceeding that of cancer. Our only chance of treating dementia is improving our understanding of how brains function at diverse levels of complexity. This will only be possible through better technologies, which already reflects...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics

MITOTARGET

Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where...

Funding Programme
Start Date
End Date
Total Funding
€ 10 332 038
European Countries Involved

Models of patient engagement for Alzheimer’s disease

MOPEAD

Dementia researchers are increasingly focusing their efforts on finding ways to prevent the onset of dementia symptoms in the first place, and for this they need to work with people who are still in the very earliest stages of the disease. The MOPEAD project aims to identify and test different models for engaging with this important group and...

Funding Programme
Start Date
End Date
Total Funding
€ 4 591 968
European Countries Involved

Molecular mechanisms of presynaptic plasticity

PreSynPlast

The ambitious goal of this project is to reveal the molecular mechanisms of presynaptic plasticity in the vertebrate brain. Synaptic plasticity occurs in the form of alterations in both presynaptic neurotransmitter release and postsynaptic receptor function. However, due to technical reasons and in contrast to intensely studied postsynaptic...

Funding Programme
Start Date
End Date
Total Funding
€ 1 609 937
European Countries Involved

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

MIRIADE

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression. With its...

Funding Programme
Start Date
End Date
Total Funding
€ 4 034 565

Multimedia technology for independence and participation for people with dementia

MYLIFE

The objective of Mylife is to support independence for older people with reduced cognitive function by giving them access to simple and intuitive services that are adapted to their individual needs and wishes. The ambition of the Mylife project is to provide network-based access to, and management of, commercially and/or freely available software...

Funding Programme
Start Date
End Date
Total Funding
€ 1 059 973
European Countries Involved

Multimodal preventive trials for Alzheimer’s Disease: towards multinational strategies

MIND-AD

The anticipated pandemic increase in the number of Alzheimer disease (AD) and dementia cases carries serious implications for society. The goal of the MIND-AD project is to identify effective prevention strategies for AD/dementia tailored to different at-risk groups. The project is based on experiences and data from five ongoing European...

Funding Programme
Start Date
End Date
Total Funding
€ 0
European Countries Involved

Music Interventions for Dementia and Depression in ELderly care (MIDDEL): International cluster-randomised trial

MIDDEL

Many older adults living in residential care homes suffer from dementia and depression. MIDDEL aims to determine if music interventions can help. Specifically, this trial will provide robust and generalisable results concerning the comparative effects of group music therapy (GMT), recreational choir singing (RCS), their combination, or standard...

Funding Programme
Start Date
End Date
Total Funding
€ 2 600 000
European Countries Involved

NAD+ International Scientist-training

NADIS

Nicotinamide adenine dinucleotide (NAD+) is a central redox cofactor and the limiting substrate of key metabolic enzymes. The constellation of cellular functions in which NAD+ is involved makes its availability critical for cell survival, and its depletion is a leading factor in a number of diseases in humans, ranging from rare inherited defects to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 530 832
European Countries Involved

Nano-diamond tracers for MRI molecular imaging

NDI

Molecular imaging is the current standard of care for the diagnosis (staging) of cancer, the evaluation of cancer treatment effectiveness, and is generating evidence as the best predictor for earlier diagnosis of Alzheimer’s disease. Molecular imaging differs from traditional imaging in that probes known as biomarkers are used to help image...

Funding Programme
Start Date
End Date
Total Funding
€ 147 500
European Countries Involved

Nanosystems for the early Diagnosis of Neurodegenerative diseases

NADINE

Medical diagnosis is currently undergoing a major revolution due to the fast discovery of molecular biomarkers, and the development of multimodal “metabiomarker” signatures. Progress, however, is hindered by low abundance of many biomarkers of interest in body fluids, in absolute concentration and with regard to other biomolecules. The aim of the...

Funding Programme
Start Date
End Date
Total Funding
€ 11 702 928
European Countries Involved

Navigation Support for Older Travellers with Memory Decline

NAVMEM

Age related memory decline, mild cognitive impairments (MCI), and cognitive impairments that occur with diseases, such as stroke, brain injuries, or early stages of dementia, have negative effects on the ability to navigate and to orient. Affected people who repeatedly start experiencing disorientation events often become scared of venturing out...

Funding Programme
Start Date
End Date
Total Funding
€ 1 980 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).